本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Neumora Therapeutics, Inc.

0.7798
+0.01281.67%
盘前0.77980.00000.00%08:34 EDT
成交量:80.47万
成交额:61.38万
市值:1.26亿
市盈率:-0.51
高:0.7798
开:0.7630
低:0.7315
收:0.7670
数据加载中...
2024/10/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report